General Information of Drug (ID: DMIBCZ5)

Drug Name
R-1315 Drug Info
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Terminated [1]
Cross-matching ID
TTD Drug ID
DMIBCZ5

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Drug(s) Targeting GPCR unspecific (GPCR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
R-873 DMDOETQ Erectile dysfunction HA01.1 Discontinued in Phase 2 [3]
R-701 DMF3A6H Overactive bladder GC50.0 Discontinued in Phase 1 [4]
R-1068 DML7M3S Vomiting MD90 Discontinued in Phase 1 [5]
R1204 DMRHF97 Depression 6A70-6A7Z Discontinued in Phase 1 [6]
R-1554 DM8XBKG Overactive bladder GC50.0 Terminated [7]
R-1437 DMBU24I Prostate hyperplasia GA90 Terminated [8]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GPCR unspecific (GPCR) TTXEU7H NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017252)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017252)
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020830)
4 R 701 Roche discontinued, USA (overactive bladder), R & D Focus Drug News. February 23, 2004
5 R 1068 Roche discontinued, Europe (emesis). R & D Focus Drug New. February 16, 2004
6 Clinical pipeline report, company report or official report of Roche.
7 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018539)
8 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017122)